Fulcrum Therapeutics, Inc. (FULC) Class Action: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Fulcrum Therapeutics, Inc. Class Action Case
June 12, 2023 19:22 ET
|
Robbins LLP
SAN DIEGO, June 12, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased Fulcrum Therapeutics, Inc....
Fulcrum Therapeutics, Inc. (FULC) Equity Alert: Contact Robbins LLP to Learn about the Fulcrum Therapeutics, Inc. Securities Fraud Class Action and Lead Plaintiff Deadline
May 23, 2023 18:26 ET
|
Robbins LLP
SAN DIEGO, May 23, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased Fulcrum Therapeutics, Inc....
Fulcrum Therapeutics, Inc. (FULC) Class Action Alert: Robbins LLP Urges Investors to Contact the Firm for Information about the Fulcrum Therapeutics, Inc. Securities Class Action
May 15, 2023 17:27 ET
|
Robbins LLP
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased Fulcrum Therapeutics, Inc....
Fulcrum Therapeutics, Inc. (FULC) Shareholder Notice: Robbins LLP Reminds Investors of Class Action Against Fulcrum Therapeutics, Inc.
May 02, 2023 17:59 ET
|
Robbins LLP
SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased Fulcrum Therapeutics, Inc....